4.8 Article

Cyclin D3 restricts SARS-CoV-2 envelope incorporation into virions and interferes with viral spread

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses

Wanwisa Dejnirattisai et al.

Summary: On November 24, 2021, the sequence of a new SARS-CoV-2 variant, Omicron-B.1.1.529, was announced. Compared to previous variants, Omicron has a higher number of mutations in the Spike (S) protein. Serum neutralization of Omicron by individuals vaccinated or previously infected with Alpha, Beta, Gamma, or Delta variants is significantly reduced or ineffective. Third vaccine doses can boost neutralization titers against Omicron, and high titers are observed in both vaccinated individuals and those infected with the Delta variant. Most potent monoclonal antibodies and antibodies under development are unable to effectively neutralize Omicron due to mutations in its Spike protein. Omicron has structural changes compared to earlier viruses and utilizes mutations that enhance its binding to ACE2, allowing for immune escape. This results in a large number of mutations in the ACE2 binding site and a rebalancing of receptor affinity similar to earlier pandemic viruses.
Article Biochemistry & Molecular Biology

Potent cross-reactive antibodies following Omicron breakthrough in vaccinees

Rungtiwa Nutalai et al.

Summary: This study compares the neutralization of Omicron variants of SARS-CoV-2 and finds that differences in neutralization mostly arise from variations in residues bordering the ACE2 binding site. Analysis of monoclonal antibodies isolated from vaccinated individuals shows that they can effectively neutralize early pandemic strains and exhibit broad reactivity with variants.
Article Biochemistry & Molecular Biology

Virological characteristics of the SARS-CoV-2 Omicron BA.2 spike

Daichi Yamasoba et al.

Summary: Research has shown that the Omicron lineage BA.1 has been outpaced by a new Omicron lineage, BA.2, which is more transmissible. Immunity induced by COVID vaccines does not effectively protect against BA.2, similar to BA.1, and BA.2 has notable antigenic differences from BA.1. BA.2 spike shows higher replication efficacy and cell fusion capability compared to BA.1 spike. Infection experiments on hamsters indicate that BA.2 spike-bearing virus is more pathogenic than BA.1 spike-bearing virus. Overall, these findings suggest that the risk of BA.2 to global health is potentially higher than that of BA.1.
Article Biochemistry & Molecular Biology

SARS-CoV-2 ORF8 reshapes the ER through forming mixed disulfides with ER oxidoreductases

Ping Liu et al.

Redox Biology (2022)

Article Microbiology

Furin cleavage of SARS-CoV-2 Spike promotes but is not essential for infection and cell-cell fusion

Guido Papa et al.

Summary: Research suggests that furin plays a promoting role in SARS-CoV-2 infectivity and cell-cell spread, but it is not essential, indicating that furin inhibitors may reduce but not completely prevent viral spread.

PLOS PATHOGENS (2021)

Article Multidisciplinary Sciences

Rapid assessment of SARS-CoV-2-evolved variants using virus-like particles

Abdullah M. Syed et al.

Summary: Efforts to determine the improved fitness of new SARS-CoV-2 variants have been limited to analyzing spike protein mutations. This study shows that SC2-VLPs can deliver exogenous transcripts, allowing analysis of mutations in all structural proteins. Specific nucleocapsid mutations were found to independently increase messenger RNA delivery and expression, shedding light on mechanisms behind the increased spread of variants.

SCIENCE (2021)

Article Biochemistry & Molecular Biology

A plasmid DNA-launched SARS-CoV-2 reverse genetics system and coronavirus toolkit for COVID-19 research

Suzannah J. Rihn et al.

Summary: The report introduces a range of tools for SARS-CoV-2 research, including a single plasmid reverse genetics system, a panel of antibodies, clinical isolates, and permissive cell lines. These tools have the potential to advance COVID-19 vaccine design, drug testing, and discovery science.

PLOS BIOLOGY (2021)

Article Cell Biology

Assembly and Entry of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2): Evaluation Using Virus-Like Particles

Binod Kumar et al.

Summary: Researchers have developed and utilized a VLP system to identify features of SARS-CoV2 assembly and entry. They found that N proteins are crucial for VLP production and secretion, and the CTDs in virus particle assembly are critical features. Furthermore, VLPs were effective at monitoring virus-cell entry, depending on host cell susceptibility factors.

CELLS (2021)

Article Cell Biology

SARS-CoV-2 envelope protein causes acute respiratory distress syndrome (ARDS)-like pathological damages and constitutes an antiviral target

Bingqing Xia et al.

Summary: The study demonstrated that the SARS-CoV-2 protein 2-E alone can cause acute respiratory distress syndrome (ARDS)-like damage and induce rapid cell death and cytokine release. Inhibiting the 2-E channel can effectively reduce the viral load and secretion of inflammation cytokines in the lungs, making it a promising drug target against SARS-CoV-2.

CELL RESEARCH (2021)

Article Multidisciplinary Sciences

The ORF8 protein of SARS-CoV-2 mediates immune evasion through down-regulating MHC-I

Yiwen Zhang et al.

Summary: COVID-19, caused by SARS-CoV-2, significantly differs from SARS in its clinical and pathological characteristics. The viral protein ORF8 of SARS-CoV-2 interacts with MHC-I molecules, leading to their down-regulation and impairment of antigen presentation system, proposing ORF8 inhibition as a potential strategy for improving immune surveillance.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Article Biochemistry & Molecular Biology

SARS-CoV-2 viral budding and entry can be modeled using BSL-2 level virus-like particles

Caroline B. Plescia et al.

Summary: The study explores a minimal system for replicating SARS-CoV-2 without using the virus' genetic material, providing a pathway for BSL-2 research. By assessing the ability of structural proteins from SARS-CoV-2 to form VLPs, the study offers important resources and methods for investigating the mechanisms of viral entry and egress from human cells.

JOURNAL OF BIOLOGICAL CHEMISTRY (2021)

Letter Biochemistry & Molecular Biology

Identification of proteasome and caspase inhibitors targeting SARS-CoV-2 Mpro

Zhengyuan Wang et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Review Microbiology

Coronavirus biology and replication: implications for SARS-CoV-2

Philip V'kovski et al.

Summary: This review discusses key aspects of coronavirus biology and their implications for SARS-CoV-2 infections, treatment, and prevention strategies. Understanding virus-host interactions at the molecular level is crucial for developing effective intervention strategies. Summarizing the discoveries of SARS-CoV-2 infection and comparing it with other coronaviruses will support future preparedness and combat strategies.

NATURE REVIEWS MICROBIOLOGY (2021)

Article Biochemistry & Molecular Biology

The Global Phosphorylation Landscape of SARS-CoV-2 Infection

Mehdi Bouhaddou et al.

Article Biotechnology & Applied Microbiology

Construction of SARS-CoV-2 Virus-Like Particles by Mammalian Expression System

Ruodan Xu et al.

FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2020)

Article Biochemistry & Molecular Biology

SARS-CoV-2 E protein is a potential ion channel that can be inhibited by Gliclazide and Memantine

Prabhat Pratap Singh Tomar et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)

Article Biochemistry & Molecular Biology

Structural and Functional Analysis of the D614G SARS-CoV-2 Spike Protein Variant

Leonid Yurkovetskiy et al.

Correction Biochemistry & Molecular Biology

SARS-CoV-2 Nsp1 binds the ribosomal mRNA channel to inhibit translation (vol 27, pg 959, 2020)

Katharina Schubert et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2020)

Article Microbiology

Integrative Imaging Reveals SARS-CoV-2-Induced Reshaping of Subcellular Morphologies

Mirko Cortese et al.

CELL HOST & MICROBE (2020)

Letter Biochemistry & Molecular Biology

A systemic and molecular study of subcellular localization of SARS-CoV-2 proteins

Jing Zhang et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)

Article Cell Biology

A quantitative FastFUCCI assay defines cell cycle dynamics at a single-cell level

Siang-Boon Koh et al.

JOURNAL OF CELL SCIENCE (2017)

Article Biochemistry & Molecular Biology

Cell Cycle-independent Role of Cyclin D3 in Host Restriction of Influenza Virus Infection

Ying Fan et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2017)

Article Biochemistry & Molecular Biology

Visualizing spatiotemporal dynamics of multicellular cell-cycle progression

Asako Sakaue-Sawano et al.

Article Biochemistry & Molecular Biology

G1 phase cell cycle arrest induced by SARS-CoV 3a protein via the cyclin D3/pRb pathway

Xiaoling Yuan et al.

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2007)

Article Biochemistry & Molecular Biology

Characterisation of cyclin D1 down-regulation in coronavirus infected cells

Sally M. Harrison et al.

FEBS LETTERS (2007)

Review Biochemistry & Molecular Biology

The M2 proton channels of influenza A and B viruses

LH Pinto et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2006)

Article Biotechnology & Applied Microbiology

Protein tagging and detection with engineered self-assembling fragments of green fluorescent protein

S Cabantous et al.

NATURE BIOTECHNOLOGY (2005)

Article Biochemistry & Molecular Biology

P38SAPK2 phosphorylates cyclin D3 at Thr-283 and targets it for proteasomal degradation

O Casanovas et al.

ONCOGENE (2004)

Article Virology

Murine coronavirus replication induces cell cycle arrest in G0/G1 phase

CJ Chen et al.

JOURNAL OF VIROLOGY (2004)

Article Biochemistry & Molecular Biology

HuR regulates cyclin A and cyclin B1 mRNA stability during cell proliferation

WG Wang et al.

EMBO JOURNAL (2000)